MYL Mylan NV

Teva Pharmaceutical Industries Ltd. said it has taken a 4.61% stake in Mylan NV, an amount that gives Teva standing in the Dutch Enterprise Chamber to commence a takeover if necessary.

Teva is in the process of trying to buy Mylan, as Mylan itself has made moves to purchase Perrigo Co. Mylan executives have sharply rebuffed Teva, stating that its offer price of $82 a share in cash and stock is far too low. Perrigo has also fended off Mylan thus far.

Teva said that if Mylan's meeting regarding the Perrigo transaction is held before September, Teva will limit its stake in Mylan to less than 5%.

Shares of Teva have increased about 3% this year through Thursday's close.

Write to Angela Chen at angela.chen@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires